Your browser doesn't support javascript.
loading
A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT).
Tomita, Noriko; Saito, Sho; Terada-Hirashima, Junko; Mikami, Ayako; Uemura, Yukari; Kutsuna, Satoshi; Nomoto, Hidetoshi; Fujisawa, Kyoko; Nagashima, Maki; Terada, Mari; Ashida, Shinobu; Morioka, Shinichiro; Satake, Masahiro; Hangaishi, Akira; Togano, Tomiteru; Shiratori, Katsuyuki; Takamatsu, Yuki; Maeda, Kenji; Ohmagari, Norio; Sugiura, Wataru; Mitsuya, Hiroaki.
Afiliação
  • Tomita N; Center for Clinical Sciences, Center Hospital of the National Center for Global Health and Medicine, Tokyo 162-8655, Japan.
  • Saito S; Disease Control and Prevention Center, Center Hospital of the National Center for Global Health and Medicine, Tokyo 162-8655, Japan.
  • Terada-Hirashima J; Center for Clinical Sciences, Center Hospital of the National Center for Global Health and Medicine, Tokyo 162-8655, Japan.
  • Mikami A; Center for Clinical Sciences, Center Hospital of the National Center for Global Health and Medicine, Tokyo 162-8655, Japan.
  • Uemura Y; Center for Clinical Sciences, Center Hospital of the National Center for Global Health and Medicine, Tokyo 162-8655, Japan.
  • Kutsuna S; Disease Control and Prevention Center, Center Hospital of the National Center for Global Health and Medicine, Tokyo 162-8655, Japan.
  • Nomoto H; Department of Infection Control and Prevention, Osaka University Hospital, Osaka 565-0871, Japan.
  • Fujisawa K; Disease Control and Prevention Center, Center Hospital of the National Center for Global Health and Medicine, Tokyo 162-8655, Japan.
  • Nagashima M; Disease Control and Prevention Center, Center Hospital of the National Center for Global Health and Medicine, Tokyo 162-8655, Japan.
  • Terada M; Disease Control and Prevention Center, Center Hospital of the National Center for Global Health and Medicine, Tokyo 162-8655, Japan.
  • Ashida S; Center for Clinical Sciences, Center Hospital of the National Center for Global Health and Medicine, Tokyo 162-8655, Japan.
  • Morioka S; Disease Control and Prevention Center, Center Hospital of the National Center for Global Health and Medicine, Tokyo 162-8655, Japan.
  • Satake M; Disease Control and Prevention Center, Center Hospital of the National Center for Global Health and Medicine, Tokyo 162-8655, Japan.
  • Hangaishi A; Disease Control and Prevention Center, Center Hospital of the National Center for Global Health and Medicine, Tokyo 162-8655, Japan.
  • Togano T; Central Blood Institute, Japanese Red Cross Society, Tokyo 135-8521, Japan.
  • Shiratori K; Department of Hematology, Center Hospital of the National Center for Global Health and Medicine, Tokyo 162-8655, Japan.
  • Takamatsu Y; Department of Hematology, Center Hospital of the National Center for Global Health and Medicine, Tokyo 162-8655, Japan.
  • Maeda K; Labotatory Testing Department, Center Hospital of the National Center for Global Health and Medicine, Tokyo 162-8655, Japan.
  • Ohmagari N; Department of Refractory Viral Infections, National Center for Global Health and Medicine Research Institute, Tokyo 162-8655, Japan.
  • Sugiura W; Department of Refractory Viral Infections, National Center for Global Health and Medicine Research Institute, Tokyo 162-8655, Japan.
  • Mitsuya H; Disease Control and Prevention Center, Center Hospital of the National Center for Global Health and Medicine, Tokyo 162-8655, Japan.
Life (Basel) ; 12(6)2022 Jun 08.
Article em En | MEDLINE | ID: mdl-35743887

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Revista: Life (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Revista: Life (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão